Conversely, CD47 mRNA expression above the mean in lung adenocarcinoma significantly correlated with improved overall survival (53 versus 41 months median survival, p = 0.021, Figure 2e), but IFT57 above the mean was more strongly associated with improved survival (58 versus 42 months median survival, p = 4.6 × 10−3, Figure 2f). The gene discussed is CD47; the disease is lung adenocarcinoma.